ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
bullishCelltrion Inc
04 Sep 2020 04:55

How Might a Celltrion Merger Look?

The key seems what happens to the value of Celltrion Holdings and in fact, the merger might not include Celltrion Inc.   The consensus belief is...

Logo
330 Views
Share
31 Aug 2020 06:29

Shorting Restriction Extension: Prolonged Arb Trade Opportunity on KOSDAQ 150 ETFs

It is now official that Korea's shorting restrictions will get a six-month extension until March 15, 2021.But the KSC is stressing that the...

Logo
278 Views
Share
bullishWuxi Biologics
16 Jul 2020 10:21

Wuxi Biologics - Recap/Learnings from past Placements

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
466 Views
Share
11 Jul 2020 14:37

Asia Short Interest Weekly - PingAn, WuXi Bio, Meituan, SMIC, Fast Retail, Sumitomo, Yageo, Genius

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
303 Views
Share
06 Jul 2020 19:30

Celltrion Healthcare: Block Deal Sale by One Equity Partners (Time to Turn Bearish)

It was announced after the market close today that One Equity Partners will sell 3.15 million shares of Celltrion Healthcare (091990 KS) shares in...

Logo
296 Views
Share
x